Osgood-Schlatter Disease
11
1
1
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (11)
State-Based Rehabilitation for Youth Athletes With Osgood-Schlatter or Sever-Related Apophyseal Pain
Low-Level Laser Therapy for Osgood-Schlatter or Sever Pain in Youth Athletes
Kinesotaping and Strengthening Exercises in Treatment of Osgood-Schlatter Disease
Safety and Efficacy of Urtica Dioica Cataplasm in the Management of Osgood-Schlatter Disease in Young Athletes
Osgood-Schlatter Disease in Athletic Children
A Comparison of Two Different Treatment Approaches for Adolescents With Osgood Schlatter
Rate of Torque Development in Adolescents With Osgood-Schlatter
Getting Kids With Osgood Schlatter Back to Performing Without Pain
Treatment for Osgood Schlatter Patients With a Physiotherapy Program
24 Month Follow-up of Patients With Osgood Schlatter (OSD)
Effectiveness of Dextrose Injection for Osgood-Schlatter Disease